(IN BRIEF) Diavantis, a Dutch company focused on supporting individuals with type 2 diabetes, has been awarded an EFRO grant to develop an innovative app aimed at guiding patients toward a medication-free life. The project, which leverages AI and IoT … Read the full press release →
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, diabetes management, Diavantis, EFRO Subsidy, Elisabeth Wilhelm, health technology, Healthcare Innovation, IoT, Lifestyle Intervention, Medication-Free Life, mobile app, partnership, type 2 diabetes, University of Groningen